Albertsons Companies Continues to Rank #1 by OutcomesMTM for Exceptional Delivery of MTM Services

After being awarded “2016 Top Large Pharmacy Chain” by OutcomesMTM, Albertsons Companies has now been named the “Top Large Pharmacy Chain” for Quarter 1 of 2017.

BOISE, ID — April 26, 2017 – After being awarded “2016 Top Large Pharmacy Chain” by OutcomesMTM, Albertsons Companies has now been named the “Top Large Pharmacy Chain” for Quarter 1 of 2017. OutcomesMTM, a Cardinal Health Company and the leading national administrator of Medication Therapy Management (MTM) services, selected Albertsons Companies for this award to recognize the company’s commitment to providing quality patient care and improving patient outcomes through drug therapy optimization.

This is the fourth quarter in a row that Albertsons Companies has been recognized by OutcomesMTM in the “Top Large Pharmacy Chain” category and the second time it has received the annual “Top Large Pharmacy Chain” award. Albertsons Companies also received the “Most Innovative Pharmacy Chain” award from OutcomesMTM in 2014.

“We’re proud of this recognition and the exceptional care our pharmacy teams provide their patients each and every day,” said Mark Panzer, Albertsons Companies Senior Vice President of Pharmacy Health and Wellness. “The demand for MTM is at an all-time high, as is the demand for accessible, quality affordable healthcare. Albertsons Companies is committed to meeting that demand by empowering our pharmacy teams to help patients take the right medications in the right way at the right time.”

Utilized in every Albertsons Companies pharmacy across the U.S., the OutcomesMTM Connect™ platform offers pharmacy teams additional opportunities to engage with patients — from performing annual comprehensive medication reviews and supporting adherence to important medications, to resolving interventions related to safety, cost, and more.

The “Top Large Pharmacy Chain” category recognizes companies that have over 900 pharmacy locations across the United States.